Yao Yong-Gang, Kajigaya Sachiko, Young Neal S
Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences & Yunnan Province, Kunming Institute of Zoology, Kunming, Yunnan 650223, China.
Hematology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20892, USA.
Mutat Res. 2015 Sep;779:68-77. doi: 10.1016/j.mrfmmm.2015.06.009. Epub 2015 Jun 22.
Determination mitochondrial DNA (mtDNA) sequences from extremely small amounts of DNA extracted from tissue of limited amounts and/or degraded samples is frequently employed in medical, forensic, and anthropologic studies. Polymerase chain reaction (PCR) amplification followed by DNA cloning is a routine method, especially to examine heteroplasmy of mtDNA mutations. In this review, we compare the mtDNA mutation patterns detected by three different sequencing strategies. Cloning and sequencing methods that are based on PCR amplification of DNA extracted from either single cells or pooled cells yield a high frequency of mutations, partly due to the artifacts introduced by PCR and/or the DNA cloning process. Direct sequencing of PCR product which has been amplified from DNA in individual cells is able to detect the low levels of mtDNA mutations present within a cell. We further summarize the findings in our recent studies that utilized this single cell method to assay mtDNA mutation patterns in different human blood cells. Our data show that many somatic mutations observed in the end-stage differentiated cells are found in hematopoietic stem cells (HSCs) and progenitors within the CD34(+) cell compartment. Accumulation of mtDNA variations in the individual CD34+ cells is affected by both aging and family genetic background. Granulocytes harbor higher numbers of mutations compared with the other cells, such as CD34(+) cells and lymphocytes. Serial assessment of mtDNA mutations in a population of single CD34(+) cells obtained from the same donor over time suggests stability of some somatic mutations. CD34(+) cell clones from a donor marked by specific mtDNA somatic mutations can be found in the recipient after transplantation. The significance of these findings is discussed in terms of the lineage tracing of HSCs, aging effect on accumulation of mtDNA mutations and the usage of mtDNA sequence in forensic identification.
从极少量的、取自有限量和/或降解样本组织的DNA中测定线粒体DNA(mtDNA)序列,在医学、法医和人类学研究中经常被采用。聚合酶链反应(PCR)扩增后进行DNA克隆是一种常规方法,特别是用于检测mtDNA突变的异质性。在本综述中,我们比较了三种不同测序策略检测到的mtDNA突变模式。基于从单个细胞或混合细胞中提取的DNA进行PCR扩增的克隆和测序方法会产生高频突变,部分原因是PCR和/或DNA克隆过程引入的假象。对从单个细胞中的DNA扩增得到的PCR产物进行直接测序,能够检测细胞内存在的低水平mtDNA突变。我们进一步总结了我们最近的研究结果,这些研究利用这种单细胞方法来分析不同人类血细胞中的mtDNA突变模式。我们的数据表明,在终末分化细胞中观察到的许多体细胞突变存在于造血干细胞(HSCs)和CD34(+)细胞区室中的祖细胞中。单个CD34+细胞中mtDNA变异的积累受衰老和家族遗传背景的影响。与其他细胞(如CD34(+)细胞和淋巴细胞)相比,粒细胞含有更多的突变。对来自同一供体的单个CD34(+)细胞群体随时间进行mtDNA突变的连续评估表明,一些体细胞突变具有稳定性。移植后,在受体中可以发现来自供体的、由特定mtDNA体细胞突变标记的CD34(+)细胞克隆。我们从造血干细胞的谱系追踪、衰老对mtDNA突变积累的影响以及mtDNA序列在法医鉴定中的应用等方面讨论了这些发现的意义。